Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
about
Autonomic neuropathy in diabetes mellitusBlood pressure control for diabetic retinopathyThe role of epigenetics in the pathology of diabetic complicationsOral insulin delivery: how far are we?A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucoseResistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memoryProgress of artificial pancreas devices towards clinical use: the first outpatient studiesTranscriptional regulation by the Set7 lysine methyltransferaseEpidemiology and natural history of gastroparesisDevelopmental changes in the roles of patients and families in type 1 diabetes managementInsulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical ExperienceOxidative stress and diabetic complicationsVascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy.Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry.The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus.Diabetic cardiovascular disease: getting to the heart of the matter.Concordance of retinopathy and nephropathy over time in Type 1 diabetes: an analysis of data from the Diabetes Control and Complications Trial.A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.Diabetic retinopathy: should this patient receive laser treatment? Overview.Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study.Current and future pharmacological intervention for diabetic retinopathy.A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization.Changing illness perceptions in patients with poorly controlled type 2 diabetes, a randomised controlled trial of a family-based intervention: protocol and pilot study.Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus.Endoplasmic reticulum stress and diabetic retinopathy.The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 StDiabetic neuropathy: mechanisms to managementThe management of diabetic neuropathy in CKD.Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetesThe natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study.Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on OsteopeniaTailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management.Effect of macular photocoagulation on visual acuity of Omani patients with clinically significant macular edema.The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic ComplicationsEffect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) StudyType 2 diabetes: postprandial hyperglycemia and increased cardiovascular riskMetabolic and hemodynamic effects of sodium-dependent glucose cotransporter 2 inhibitors on cardio-renal protection in the treatment of patients with type 2 diabetes mellitusPrediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study.Diabetic retinopathy (treatment)
P2860
Q21131270-E3FE0DE7-0E27-4D46-8752-00FB3D3CBA41Q24186434-34592D85-DB9F-470A-A5E6-9181808FE8C3Q24609124-A9BB9EA0-7A0E-457D-B475-54EF092A5D29Q24632900-2DE96F96-5DE7-4D5B-B71C-FB5F760329E0Q24642266-3E1D7CAF-6210-4359-B319-89292FE6262AQ24647760-6D62C680-9A7A-4331-8A67-DFB4532FBE15Q26825236-4DD79B25-2F73-4BDA-A03E-397CA69CB228Q27009508-38C286B6-7E18-46B4-A8A9-60AECE7E4EB1Q27025141-E608D2B8-B0C7-4F85-8D7A-29CA01EB7FE8Q28083966-1D9ACAF2-5EB4-46F9-8481-4658ADD801FAQ28085428-7808E0E9-6652-4AC9-A208-316D56C435AEQ29615423-BA6837CA-71C2-46A8-95E1-B1561BB30445Q30244247-CCFFD86B-A5ED-4049-B2F5-E4ED898E75A2Q30279053-0BB43921-3436-43C4-9C08-ED249511D9BAQ30409961-3B581025-939F-49A6-A4B4-6E777658EAE5Q30437526-0C42E6A2-5823-4949-9346-3D6661800D57Q30451529-B12250A0-D6C5-4AC9-AF49-6FDC00482D5FQ30658906-7DCF3482-83B1-4703-BFB0-7938A04A0D89Q31164826-BCBBE76D-C1AE-4623-AA4C-93C599922232Q33198523-B7A3608A-8DD8-4855-A2FA-9BB256904839Q33204471-0D71F841-0BA9-4C12-B173-C3BCBC7B3489Q33216425-8794F578-C2B0-4781-BD34-1C344F521A4DQ33269618-2685CC67-1771-4980-8A2F-1AA3540D94D0Q33289137-2D47DFFB-F986-4B8F-86F3-DFD929E0F2AEQ33312930-ECA5628E-AF2E-4202-8245-EE1E1639F343Q33352111-99DE59AA-5423-49CE-8F18-24A32874D2B2Q33438530-C92758B2-D3EC-479A-800D-853556BCF136Q33554384-7DCBEB07-75E6-4B5B-B177-B73C40E6166DQ33554396-CEC568A9-B6A5-4749-8C38-2325A2F141B4Q33569031-396AC37F-2295-4CAA-A18E-E1794DB1A48EQ33588129-499B02B1-FFA1-4FF8-934C-D68C04BD3E7EQ33588206-2DD1AEFA-A016-4512-9BC4-06CC34B7ADA7Q33621591-7609677A-2BF8-4632-850F-1FD0A38130DAQ33645419-BCF2C331-F04E-423B-A62E-1A5C0C97B59CQ33749208-C29D2400-BF54-4D0E-A036-F6EE288335C4Q33804684-5CA7E123-F688-4146-8473-82002BCA7F3BQ33813768-A90EEB99-62D1-4FF7-AB4B-7F0713E09464Q33871321-12FD017D-3A32-4CCD-A075-39C576C7E410Q33879458-0F5623B6-C6A5-468F-8990-66AA318FAA33Q33910631-EF9A48C8-098D-4197-86D8-5EFA2FC425F9
P2860
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of intensive therapy on ...... s of type 1 diabetes mellitus.
@en
Effect of intensive therapy on ...... s of type 1 diabetes mellitus.
@nl
type
label
Effect of intensive therapy on ...... s of type 1 diabetes mellitus.
@en
Effect of intensive therapy on ...... s of type 1 diabetes mellitus.
@nl
prefLabel
Effect of intensive therapy on ...... s of type 1 diabetes mellitus.
@en
Effect of intensive therapy on ...... s of type 1 diabetes mellitus.
@nl
P2860
P356
P1476
Effect of intensive therapy on ...... s of type 1 diabetes mellitus.
@en
P2093
Writing Team for the Diabetes ...... d Complications Research Group
P2860
P304
P356
10.1001/JAMA.287.19.2563
P407
P577
2002-05-01T00:00:00Z